| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Translocation, Genetic | 13 | 2005 | 74 | 1.360 |
Why?
|
| In Situ Hybridization, Fluorescence | 20 | 2005 | 144 | 1.360 |
Why?
|
| Chromosome Aberrations | 15 | 2005 | 86 | 1.340 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 16 | 2005 | 63 | 1.170 |
Why?
|
| Karyotyping | 22 | 2005 | 74 | 0.820 |
Why?
|
| Myelodysplastic Syndromes | 6 | 2005 | 24 | 0.640 |
Why?
|
| Pathology, Clinical | 2 | 2016 | 16 | 0.640 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 5 | 2014 | 70 | 0.630 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 6 | 2005 | 44 | 0.530 |
Why?
|
| Leukemia | 5 | 2001 | 117 | 0.520 |
Why?
|
| Chromosomes, Human, Pair 16 | 3 | 2005 | 18 | 0.500 |
Why?
|
| Chromosome Banding | 5 | 2003 | 24 | 0.490 |
Why?
|
| Cytogenetics | 4 | 2000 | 7 | 0.470 |
Why?
|
| Leukemia, Myeloid, Acute | 4 | 2005 | 116 | 0.460 |
Why?
|
| Chromosomes, Human, Pair 11 | 6 | 2005 | 32 | 0.400 |
Why?
|
| Chromosomes, Human, Pair 8 | 7 | 2004 | 54 | 0.360 |
Why?
|
| Blast Crisis | 5 | 2005 | 7 | 0.350 |
Why?
|
| Leishmaniasis, Visceral | 6 | 1990 | 9 | 0.340 |
Why?
|
| Neoplasms | 7 | 1998 | 1667 | 0.310 |
Why?
|
| Humans | 95 | 2016 | 68618 | 0.310 |
Why?
|
| Philadelphia Chromosome | 4 | 2001 | 7 | 0.310 |
Why?
|
| Bone Marrow | 10 | 2005 | 168 | 0.280 |
Why?
|
| Thrombocytopenia | 3 | 1994 | 122 | 0.280 |
Why?
|
| Trisomy | 4 | 2004 | 47 | 0.270 |
Why?
|
| Chromosome Painting | 2 | 2003 | 3 | 0.270 |
Why?
|
| Blood Coagulation Disorders | 2 | 1997 | 45 | 0.260 |
Why?
|
| Chromosomes, Human, Pair 22 | 2 | 2003 | 18 | 0.260 |
Why?
|
| Lymphocyte Activation | 5 | 1989 | 397 | 0.250 |
Why?
|
| Fusion Proteins, bcr-abl | 5 | 2014 | 37 | 0.250 |
Why?
|
| Chromosome Disorders | 3 | 2001 | 31 | 0.240 |
Why?
|
| Bone Marrow Cells | 10 | 2003 | 217 | 0.240 |
Why?
|
| Nuclear Proteins | 5 | 1997 | 271 | 0.240 |
Why?
|
| Blood Donors | 2 | 1995 | 18 | 0.240 |
Why?
|
| Chromosome Mapping | 2 | 2001 | 188 | 0.230 |
Why?
|
| Lymphoma, Non-Hodgkin | 2 | 2003 | 36 | 0.230 |
Why?
|
| Agranulocytosis | 6 | 1989 | 15 | 0.220 |
Why?
|
| Humerus | 1 | 2003 | 23 | 0.220 |
Why?
|
| Neutropenia | 6 | 1989 | 72 | 0.220 |
Why?
|
| Lymphoma, Mantle-Cell | 4 | 2005 | 9 | 0.210 |
Why?
|
| Sarcoma, Ewing | 1 | 2003 | 26 | 0.210 |
Why?
|
| Blood Platelets | 2 | 1994 | 284 | 0.210 |
Why?
|
| Adult | 35 | 2005 | 21403 | 0.200 |
Why?
|
| Bone Neoplasms | 1 | 2003 | 100 | 0.200 |
Why?
|
| Multiple Myeloma | 2 | 2000 | 92 | 0.200 |
Why?
|
| Neutrophils | 7 | 1989 | 204 | 0.200 |
Why?
|
| HIV Antibodies | 2 | 1992 | 28 | 0.200 |
Why?
|
| Antineoplastic Agents | 8 | 2005 | 1070 | 0.200 |
Why?
|
| Prognosis | 13 | 2005 | 2093 | 0.190 |
Why?
|
| Leukemia, Promyelocytic, Acute | 4 | 2005 | 17 | 0.190 |
Why?
|
| Interphase | 4 | 2005 | 19 | 0.190 |
Why?
|
| Female | 52 | 2010 | 38074 | 0.190 |
Why?
|
| Male | 45 | 2010 | 37321 | 0.190 |
Why?
|
| Lymphocytes | 4 | 2001 | 228 | 0.180 |
Why?
|
| Lymphoma, B-Cell | 2 | 2000 | 40 | 0.180 |
Why?
|
| Biliary Tract Diseases | 2 | 1990 | 50 | 0.170 |
Why?
|
| Middle Aged | 34 | 2010 | 21147 | 0.170 |
Why?
|
| Antigens, Surface | 3 | 1989 | 71 | 0.170 |
Why?
|
| Chromosomes, Human, Pair 6 | 2 | 2001 | 20 | 0.170 |
Why?
|
| DNA Probes | 2 | 2000 | 57 | 0.160 |
Why?
|
| Chromosome Deletion | 4 | 2004 | 41 | 0.160 |
Why?
|
| Lymphoma | 3 | 2005 | 116 | 0.160 |
Why?
|
| History, 20th Century | 2 | 2016 | 248 | 0.160 |
Why?
|
| B-Lymphocytes | 5 | 1985 | 329 | 0.160 |
Why?
|
| Azure Stains | 1 | 1998 | 4 | 0.160 |
Why?
|
| T-Lymphocytes | 6 | 1990 | 597 | 0.160 |
Why?
|
| Leukemia, Prolymphocytic | 1 | 1998 | 1 | 0.150 |
Why?
|
| Centromere | 1 | 1998 | 15 | 0.150 |
Why?
|
| Aged | 26 | 2005 | 14862 | 0.150 |
Why?
|
| Leishmania donovani | 5 | 1990 | 19 | 0.150 |
Why?
|
| Liver Diseases | 2 | 1990 | 193 | 0.150 |
Why?
|
| Autoantibodies | 4 | 1989 | 434 | 0.150 |
Why?
|
| Hemostasis | 1 | 1997 | 32 | 0.150 |
Why?
|
| Chromosomes, Human, Pair 1 | 2 | 2004 | 28 | 0.150 |
Why?
|
| Chromosomes, Human, Pair 7 | 5 | 2005 | 18 | 0.140 |
Why?
|
| Isoantigens | 2 | 1994 | 26 | 0.140 |
Why?
|
| Flow Cytometry | 7 | 2005 | 489 | 0.140 |
Why?
|
| Immunization | 2 | 1988 | 86 | 0.140 |
Why?
|
| Cytogenetic Analysis | 3 | 2001 | 12 | 0.140 |
Why?
|
| Diabetes Mellitus | 5 | 1993 | 694 | 0.140 |
Why?
|
| Chromosomes, Human, Pair 10 | 1 | 1996 | 10 | 0.130 |
Why?
|
| Leukemia, Monocytic, Acute | 1 | 1996 | 9 | 0.130 |
Why?
|
| X Chromosome | 1 | 1996 | 28 | 0.130 |
Why?
|
| Breast Neoplasms | 4 | 2004 | 1536 | 0.130 |
Why?
|
| HTLV-I Antibodies | 1 | 1995 | 2 | 0.130 |
Why?
|
| HTLV-II Antibodies | 1 | 1995 | 2 | 0.130 |
Why?
|
| Leukemia, Megakaryoblastic, Acute | 1 | 1995 | 2 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 1995 | 9 | 0.130 |
Why?
|
| Neoplasm Proteins | 6 | 2004 | 307 | 0.130 |
Why?
|
| Leukocyte Count | 4 | 1997 | 94 | 0.130 |
Why?
|
| Hemorrhage | 1 | 1997 | 328 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 5 | 3 | 2002 | 9 | 0.130 |
Why?
|
| History, 21st Century | 1 | 2016 | 127 | 0.130 |
Why?
|
| Thrombosis | 2 | 1994 | 218 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 17 | 3 | 2004 | 15 | 0.120 |
Why?
|
| Cloning, Molecular | 1 | 1995 | 357 | 0.120 |
Why?
|
| Proto-Oncogene Proteins | 4 | 2005 | 411 | 0.120 |
Why?
|
| Transcription Factor 7-Like 1 Protein | 1 | 2014 | 1 | 0.120 |
Why?
|
| SOXC Transcription Factors | 1 | 2014 | 4 | 0.120 |
Why?
|
| Antibodies, Monoclonal | 4 | 2005 | 511 | 0.120 |
Why?
|
| Immunophenotyping | 7 | 2005 | 110 | 0.120 |
Why?
|
| Leukemia, Myeloid | 2 | 2004 | 39 | 0.120 |
Why?
|
| Blotting, Western | 4 | 1996 | 954 | 0.110 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 6 | 2005 | 710 | 0.110 |
Why?
|
| Chemistry, Clinical | 1 | 1993 | 6 | 0.110 |
Why?
|
| Nucleic Acid Hybridization | 2 | 2005 | 95 | 0.110 |
Why?
|
| Pyrimidines | 2 | 2004 | 178 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 9 | 2 | 2004 | 23 | 0.110 |
Why?
|
| Piperazines | 2 | 2004 | 206 | 0.110 |
Why?
|
| HIV-2 | 1 | 1992 | 4 | 0.110 |
Why?
|
| Neoplasms, Second Primary | 2 | 2005 | 62 | 0.100 |
Why?
|
| Vidarabine | 2 | 2005 | 12 | 0.100 |
Why?
|
| Oncogene Proteins, Fusion | 4 | 2005 | 18 | 0.100 |
Why?
|
| Clinical Medicine | 1 | 1991 | 20 | 0.090 |
Why?
|
| Autoimmune Diseases | 3 | 1988 | 186 | 0.090 |
Why?
|
| Extravascular Lung Water | 1 | 2010 | 5 | 0.090 |
Why?
|
| Clinical Laboratory Techniques | 1 | 1991 | 60 | 0.090 |
Why?
|
| Aged, 80 and over | 9 | 2005 | 4848 | 0.090 |
Why?
|
| Capillary Permeability | 1 | 2010 | 69 | 0.090 |
Why?
|
| Pulmonary Edema | 1 | 2010 | 37 | 0.090 |
Why?
|
| Ethics, Medical | 1 | 1991 | 86 | 0.090 |
Why?
|
| Serum Albumin | 1 | 2010 | 104 | 0.090 |
Why?
|
| Biomarkers, Tumor | 4 | 2004 | 508 | 0.090 |
Why?
|
| Blood Platelet Disorders | 1 | 1990 | 4 | 0.090 |
Why?
|
| Antilymphocyte Serum | 1 | 1990 | 52 | 0.090 |
Why?
|
| Thrombasthenia | 1 | 1990 | 3 | 0.090 |
Why?
|
| Thrombocytosis | 1 | 1990 | 7 | 0.090 |
Why?
|
| Bone Marrow Neoplasms | 2 | 2000 | 3 | 0.090 |
Why?
|
| Immunity, Cellular | 1 | 1990 | 80 | 0.090 |
Why?
|
| Aging | 1 | 1996 | 911 | 0.090 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 1990 | 123 | 0.090 |
Why?
|
| Immunotherapy | 2 | 2005 | 215 | 0.080 |
Why?
|
| Sperm Motility | 1 | 1988 | 41 | 0.080 |
Why?
|
| Cell Cycle | 4 | 1998 | 312 | 0.080 |
Why?
|
| Trichomonas vaginalis | 1 | 1988 | 22 | 0.080 |
Why?
|
| Killer Cells, Natural | 1 | 1989 | 94 | 0.080 |
Why?
|
| Interleukin-2 | 1 | 1989 | 133 | 0.080 |
Why?
|
| Transcription Factors | 3 | 1997 | 753 | 0.080 |
Why?
|
| Aluminum Hydroxide | 1 | 1988 | 3 | 0.080 |
Why?
|
| Biopsy, Needle | 3 | 2004 | 191 | 0.080 |
Why?
|
| Bone Marrow Transplantation | 2 | 2000 | 149 | 0.080 |
Why?
|
| Antigens, CD | 3 | 2004 | 230 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 14 | 2 | 2005 | 16 | 0.080 |
Why?
|
| Adjuvants, Immunologic | 1 | 1988 | 63 | 0.070 |
Why?
|
| Tumor Suppressor Proteins | 4 | 1997 | 194 | 0.070 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 2 | 2005 | 100 | 0.070 |
Why?
|
| Cell Transformation, Neoplastic | 3 | 2014 | 235 | 0.070 |
Why?
|
| Gene Deletion | 3 | 2001 | 235 | 0.070 |
Why?
|
| Polymerase Chain Reaction | 2 | 1998 | 492 | 0.070 |
Why?
|
| Lac Operon | 2 | 1997 | 54 | 0.070 |
Why?
|
| Hydroxyethyl Starch Derivatives | 1 | 1986 | 24 | 0.070 |
Why?
|
| Starch | 1 | 1986 | 18 | 0.070 |
Why?
|
| Metaphase | 3 | 2001 | 12 | 0.070 |
Why?
|
| Disease Progression | 2 | 2014 | 1038 | 0.070 |
Why?
|
| Plant Proteins | 2 | 2003 | 48 | 0.070 |
Why?
|
| Sensitivity and Specificity | 5 | 2002 | 1753 | 0.070 |
Why?
|
| Immunohistochemistry | 7 | 2004 | 1174 | 0.070 |
Why?
|
| Erythropoietin | 2 | 1997 | 96 | 0.070 |
Why?
|
| Mice | 11 | 2014 | 8474 | 0.070 |
Why?
|
| Chromosome Inversion | 1 | 2005 | 5 | 0.070 |
Why?
|
| Lung | 1 | 2010 | 849 | 0.070 |
Why?
|
| Myeloproliferative Disorders | 2 | 1997 | 11 | 0.060 |
Why?
|
| HIV Infections | 2 | 1992 | 791 | 0.060 |
Why?
|
| Genes, Tumor Suppressor | 2 | 1995 | 61 | 0.060 |
Why?
|
| Mitoxantrone | 1 | 2005 | 7 | 0.060 |
Why?
|
| Glucose | 2 | 1980 | 307 | 0.060 |
Why?
|
| Nipples | 1 | 2004 | 5 | 0.060 |
Why?
|
| Animals | 15 | 2014 | 20881 | 0.060 |
Why?
|
| Interferon-alpha | 1 | 2005 | 46 | 0.060 |
Why?
|
| Leukemia, Myeloid, Accelerated Phase | 1 | 2004 | 2 | 0.060 |
Why?
|
| Retrospective Studies | 7 | 2004 | 7277 | 0.060 |
Why?
|
| Mammary Glands, Human | 1 | 2004 | 33 | 0.060 |
Why?
|
| CD2 Antigens | 1 | 2004 | 8 | 0.060 |
Why?
|
| Dexamethasone | 1 | 2005 | 150 | 0.060 |
Why?
|
| United States | 2 | 2016 | 7367 | 0.060 |
Why?
|
| Insulin | 2 | 1981 | 619 | 0.060 |
Why?
|
| Diagnosis, Differential | 3 | 2000 | 1140 | 0.060 |
Why?
|
| Bone Marrow Purging | 1 | 2003 | 2 | 0.060 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2003 | 30 | 0.060 |
Why?
|
| HL-60 Cells | 1 | 2003 | 50 | 0.060 |
Why?
|
| Immunotoxins | 1 | 2003 | 23 | 0.060 |
Why?
|
| Chromosomes, Human | 2 | 2004 | 14 | 0.050 |
Why?
|
| RNA, Messenger | 3 | 2014 | 1664 | 0.050 |
Why?
|
| DNA, Neoplasm | 2 | 2000 | 95 | 0.050 |
Why?
|
| Promyelocytic Leukemia Protein | 3 | 1997 | 3 | 0.050 |
Why?
|
| Leukemia, Myelomonocytic, Chronic | 1 | 2002 | 5 | 0.050 |
Why?
|
| Ovarian Neoplasms | 1 | 2004 | 267 | 0.050 |
Why?
|
| Epithelial Cells | 1 | 2004 | 431 | 0.050 |
Why?
|
| Waldenstrom Macroglobulinemia | 1 | 2001 | 10 | 0.050 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2005 | 468 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 2001 | 17 | 0.050 |
Why?
|
| Leukemia, B-Cell | 1 | 2001 | 7 | 0.050 |
Why?
|
| Pokeweed Mitogens | 1 | 1981 | 9 | 0.050 |
Why?
|
| Phytohemagglutinins | 1 | 1981 | 16 | 0.050 |
Why?
|
| Concanavalin A | 1 | 1981 | 22 | 0.050 |
Why?
|
| Genes, myc | 1 | 2001 | 26 | 0.050 |
Why?
|
| Hydroxyurea | 1 | 2001 | 57 | 0.050 |
Why?
|
| Chromosome Breakage | 1 | 2000 | 6 | 0.050 |
Why?
|
| Mice, Transgenic | 4 | 2014 | 1033 | 0.050 |
Why?
|
| Chromosome Fragility | 1 | 2000 | 10 | 0.050 |
Why?
|
| Diabetes Complications | 2 | 1993 | 249 | 0.050 |
Why?
|
| Pregnancy | 2 | 1985 | 2334 | 0.050 |
Why?
|
| Tumor Cells, Cultured | 3 | 1997 | 852 | 0.050 |
Why?
|
| Leukemia, Myelomonocytic, Acute | 1 | 2000 | 3 | 0.040 |
Why?
|
| Carcinosarcoma | 1 | 2000 | 12 | 0.040 |
Why?
|
| Transcription, Genetic | 1 | 2002 | 562 | 0.040 |
Why?
|
| Burkitt Lymphoma | 1 | 2000 | 18 | 0.040 |
Why?
|
| Prostatic Neoplasms | 2 | 1996 | 778 | 0.040 |
Why?
|
| Sickle Cell Trait | 1 | 1980 | 24 | 0.040 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2000 | 47 | 0.040 |
Why?
|
| Anemia, Sickle Cell | 2 | 1980 | 364 | 0.040 |
Why?
|
| Reproducibility of Results | 2 | 2010 | 2077 | 0.040 |
Why?
|
| Cells, Cultured | 2 | 2001 | 2673 | 0.040 |
Why?
|
| Radiography | 2 | 2010 | 572 | 0.040 |
Why?
|
| Vaccines | 2 | 1990 | 21 | 0.040 |
Why?
|
| Liver | 3 | 1996 | 1118 | 0.040 |
Why?
|
| Trypsin | 1 | 1998 | 64 | 0.040 |
Why?
|
| RNA-Directed DNA Polymerase | 1 | 1998 | 11 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 1998 | 16 | 0.040 |
Why?
|
| Survival Analysis | 4 | 2002 | 714 | 0.040 |
Why?
|
| Staining and Labeling | 1 | 1998 | 144 | 0.040 |
Why?
|
| Cytodiagnosis | 1 | 1998 | 20 | 0.040 |
Why?
|
| CDC2-CDC28 Kinases | 1 | 1997 | 17 | 0.040 |
Why?
|
| Blood Coagulation Factors | 1 | 1997 | 44 | 0.040 |
Why?
|
| Cyclin D1 | 3 | 2003 | 37 | 0.040 |
Why?
|
| Gene Expression Profiling | 2 | 2014 | 498 | 0.040 |
Why?
|
| Cisplatin | 2 | 1997 | 192 | 0.040 |
Why?
|
| DNA Adducts | 1 | 1997 | 7 | 0.040 |
Why?
|
| Radiotherapy | 1 | 1997 | 86 | 0.040 |
Why?
|
| DNA, Antisense | 1 | 1997 | 9 | 0.040 |
Why?
|
| Blood Protein Electrophoresis | 1 | 1997 | 7 | 0.040 |
Why?
|
| Monoclonal Gammopathy of Undetermined Significance | 1 | 1997 | 5 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 3 | 1990 | 2791 | 0.040 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 1997 | 32 | 0.040 |
Why?
|
| Microscopy, Fluorescence | 1 | 1998 | 261 | 0.040 |
Why?
|
| Blood Coagulation | 1 | 1997 | 123 | 0.040 |
Why?
|
| Receptors, Retinoic Acid | 1 | 1997 | 48 | 0.040 |
Why?
|
| Leukapheresis | 1 | 1997 | 8 | 0.040 |
Why?
|
| Transgenes | 1 | 1997 | 92 | 0.040 |
Why?
|
| Kidney Tubules, Proximal | 1 | 1997 | 81 | 0.040 |
Why?
|
| Alleles | 2 | 1995 | 386 | 0.040 |
Why?
|
| Lymphoproliferative Disorders | 1 | 1997 | 37 | 0.040 |
Why?
|
| Calcitonin | 1 | 1996 | 21 | 0.040 |
Why?
|
| Blood Component Removal | 1 | 1997 | 19 | 0.040 |
Why?
|
| Formaldehyde | 1 | 1997 | 48 | 0.040 |
Why?
|
| Blood Proteins | 1 | 1997 | 94 | 0.040 |
Why?
|
| DNA, Complementary | 1 | 1997 | 251 | 0.040 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 1996 | 43 | 0.030 |
Why?
|
| Carcinoma, Small Cell | 1 | 1996 | 53 | 0.030 |
Why?
|
| Tissue Fixation | 1 | 1997 | 58 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2004 | 2550 | 0.030 |
Why?
|
| DNA Repair | 1 | 1997 | 127 | 0.030 |
Why?
|
| Child, Preschool | 4 | 2004 | 3187 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 1997 | 756 | 0.030 |
Why?
|
| Follow-Up Studies | 4 | 2005 | 3259 | 0.030 |
Why?
|
| Epitopes | 2 | 1994 | 146 | 0.030 |
Why?
|
| Molecular Sequence Data | 4 | 2002 | 1447 | 0.030 |
Why?
|
| Autoantigens | 2 | 1988 | 91 | 0.030 |
Why?
|
| Cell Line, Tumor | 2 | 2014 | 1851 | 0.030 |
Why?
|
| fms-Like Tyrosine Kinase 3 | 2 | 2005 | 21 | 0.030 |
Why?
|
| In Vitro Techniques | 2 | 2003 | 765 | 0.030 |
Why?
|
| Remission Induction | 2 | 2005 | 111 | 0.030 |
Why?
|
| Platelet Membrane Glycoproteins | 1 | 1994 | 19 | 0.030 |
Why?
|
| Imatinib Mesylate | 2 | 2004 | 26 | 0.030 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2014 | 29 | 0.030 |
Why?
|
| Cell Separation | 3 | 2001 | 132 | 0.030 |
Why?
|
| Melanoma | 1 | 1998 | 335 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2004 | 376 | 0.030 |
Why?
|
| Carcinoma | 1 | 1996 | 215 | 0.030 |
Why?
|
| Disease-Free Survival | 2 | 2005 | 349 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2014 | 132 | 0.030 |
Why?
|
| Portal Vein | 1 | 1994 | 46 | 0.030 |
Why?
|
| Agglutination Tests | 3 | 1989 | 9 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 2014 | 219 | 0.030 |
Why?
|
| Adolescent | 5 | 2004 | 8912 | 0.030 |
Why?
|
| RNA Interference | 1 | 2014 | 266 | 0.030 |
Why?
|
| Cell Cycle Proteins | 1 | 1995 | 230 | 0.030 |
Why?
|
| Benzamides | 2 | 2004 | 156 | 0.030 |
Why?
|
| Platelet Adhesiveness | 1 | 1993 | 20 | 0.030 |
Why?
|
| Laboratories | 1 | 1993 | 44 | 0.030 |
Why?
|
| Platelet Aggregation | 1 | 1993 | 127 | 0.030 |
Why?
|
| Antibody Specificity | 3 | 1988 | 98 | 0.030 |
Why?
|
| Arteriosclerosis | 1 | 1993 | 137 | 0.030 |
Why?
|
| Base Sequence | 3 | 2002 | 1015 | 0.030 |
Why?
|
| Immunoenzyme Techniques | 1 | 1992 | 196 | 0.030 |
Why?
|
| Uremia | 1 | 1972 | 10 | 0.030 |
Why?
|
| Monosomy | 2 | 2005 | 6 | 0.030 |
Why?
|
| Acute Disease | 2 | 2004 | 658 | 0.030 |
Why?
|
| HIV Seropositivity | 1 | 1992 | 66 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 1995 | 597 | 0.030 |
Why?
|
| Spleen | 3 | 1988 | 301 | 0.030 |
Why?
|
| Myocardial Ischemia | 1 | 1993 | 172 | 0.030 |
Why?
|
| Mood Disorders | 1 | 1993 | 132 | 0.030 |
Why?
|
| Kidney | 1 | 1996 | 945 | 0.020 |
Why?
|
| Renal Dialysis | 1 | 1972 | 174 | 0.020 |
Why?
|
| Glucans | 1 | 1990 | 12 | 0.020 |
Why?
|
| Reagent Kits, Diagnostic | 1 | 1990 | 54 | 0.020 |
Why?
|
| Survival Rate | 3 | 1999 | 1056 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 13 | 2 | 2001 | 18 | 0.020 |
Why?
|
| X-Rays | 1 | 1990 | 56 | 0.020 |
Why?
|
| Cell Count | 2 | 2002 | 248 | 0.020 |
Why?
|
| Organ Specificity | 1 | 1990 | 167 | 0.020 |
Why?
|
| Mutation | 2 | 2005 | 1213 | 0.020 |
Why?
|
| Granulocytes | 1 | 1989 | 22 | 0.020 |
Why?
|
| Immunologic Tests | 1 | 1989 | 9 | 0.020 |
Why?
|
| Depressive Disorder | 1 | 1993 | 621 | 0.020 |
Why?
|
| Reference Values | 2 | 2002 | 579 | 0.020 |
Why?
|
| Trypsin Inhibitors | 1 | 1988 | 15 | 0.020 |
Why?
|
| Chromatography, Gel | 1 | 1988 | 79 | 0.020 |
Why?
|
| Agglutination | 1 | 1988 | 3 | 0.020 |
Why?
|
| Isoantibodies | 2 | 1985 | 35 | 0.020 |
Why?
|
| Immunosorbent Techniques | 1 | 1988 | 18 | 0.020 |
Why?
|
| Kidney Failure, Chronic | 1 | 1972 | 365 | 0.020 |
Why?
|
| False Negative Reactions | 2 | 2000 | 63 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2010 | 652 | 0.020 |
Why?
|
| Critical Care | 1 | 2010 | 263 | 0.020 |
Why?
|
| Transplantation, Homologous | 2 | 2000 | 242 | 0.020 |
Why?
|
| Infant | 4 | 1988 | 2891 | 0.020 |
Why?
|
| Ultrasonography | 1 | 1990 | 453 | 0.020 |
Why?
|
| Hodgkin Disease | 1 | 1987 | 27 | 0.020 |
Why?
|
| Mononuclear Phagocyte System | 1 | 1986 | 8 | 0.020 |
Why?
|
| Hyperplasia | 1 | 1987 | 89 | 0.020 |
Why?
|
| Treatment Outcome | 3 | 2004 | 7029 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 2 | 1997 | 24 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 1990 | 1465 | 0.020 |
Why?
|
| Agglutinins | 1 | 1986 | 1 | 0.020 |
Why?
|
| Immunization, Passive | 1 | 1985 | 24 | 0.020 |
Why?
|
| Myosin Heavy Chains | 1 | 2005 | 49 | 0.020 |
Why?
|
| Mitogens | 1 | 1985 | 45 | 0.020 |
Why?
|
| Antigens | 2 | 1982 | 90 | 0.020 |
Why?
|
| Lymph Nodes | 1 | 1987 | 258 | 0.020 |
Why?
|
| Computers | 1 | 1985 | 63 | 0.020 |
Why?
|
| HLA Antigens | 1 | 1985 | 82 | 0.020 |
Why?
|
| Probability | 2 | 2002 | 245 | 0.020 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2005 | 33 | 0.020 |
Why?
|
| Phenotype | 2 | 1999 | 947 | 0.020 |
Why?
|
| Vaccination | 1 | 1986 | 189 | 0.020 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2005 | 76 | 0.020 |
Why?
|
| BCG Vaccine | 1 | 1984 | 12 | 0.020 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 1985 | 75 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2005 | 282 | 0.020 |
Why?
|
| Tretinoin | 1 | 2005 | 92 | 0.020 |
Why?
|
| Neoplasm Staging | 2 | 1998 | 800 | 0.020 |
Why?
|
| Rituximab | 1 | 2005 | 61 | 0.020 |
Why?
|
| Interferons | 1 | 2004 | 36 | 0.020 |
Why?
|
| Oncogene Proteins | 1 | 2004 | 35 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 21 | 1 | 2004 | 9 | 0.020 |
Why?
|
| Basophils | 1 | 2004 | 57 | 0.010 |
Why?
|
| Fetal Blood | 1 | 1984 | 131 | 0.010 |
Why?
|
| Antigens, Polyomavirus Transforming | 1 | 2004 | 15 | 0.010 |
Why?
|
| RNA Precursors | 1 | 2004 | 14 | 0.010 |
Why?
|
| Abrin | 1 | 1984 | 1 | 0.010 |
Why?
|
| Ricin | 1 | 1984 | 6 | 0.010 |
Why?
|
| DNA Primers | 1 | 2004 | 302 | 0.010 |
Why?
|
| Genes, ras | 1 | 2004 | 46 | 0.010 |
Why?
|
| DNA Damage | 1 | 2005 | 190 | 0.010 |
Why?
|
| Age Factors | 1 | 1988 | 1864 | 0.010 |
Why?
|
| Sialic Acid Binding Ig-like Lectin 3 | 1 | 2003 | 7 | 0.010 |
Why?
|
| Tumor Stem Cell Assay | 1 | 2003 | 30 | 0.010 |
Why?
|
| Ribosome Inactivating Proteins, Type 1 | 1 | 2003 | 21 | 0.010 |
Why?
|
| Telomerase | 1 | 2004 | 85 | 0.010 |
Why?
|
| Colony-Forming Units Assay | 1 | 2003 | 78 | 0.010 |
Why?
|
| Software | 1 | 1985 | 418 | 0.010 |
Why?
|
| Genes, abl | 1 | 2002 | 4 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2005 | 951 | 0.010 |
Why?
|
| Anemia, Refractory, with Excess of Blasts | 1 | 2002 | 3 | 0.010 |
Why?
|
| Culture Techniques | 1 | 2002 | 65 | 0.010 |
Why?
|
| Blood Cells | 1 | 2002 | 27 | 0.010 |
Why?
|
| Y Chromosome | 1 | 2001 | 5 | 0.010 |
Why?
|
| Ploidies | 1 | 2001 | 6 | 0.010 |
Why?
|
| NF-kappa B | 1 | 2004 | 432 | 0.010 |
Why?
|
| CD5 Antigens | 1 | 2001 | 5 | 0.010 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2003 | 268 | 0.010 |
Why?
|
| Hemoglobins | 1 | 2002 | 120 | 0.010 |
Why?
|
| Receptors, IgE | 1 | 2001 | 22 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2003 | 742 | 0.010 |
Why?
|
| Hexosephosphates | 1 | 1980 | 4 | 0.010 |
Why?
|
| Gene Expression Regulation | 2 | 1997 | 1293 | 0.010 |
Why?
|
| Citric Acid Cycle | 1 | 1980 | 15 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 2000 | 67 | 0.010 |
Why?
|
| Gene Rearrangement | 1 | 2000 | 19 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 1990 | 2223 | 0.010 |
Why?
|
| Idarubicin | 1 | 2000 | 4 | 0.010 |
Why?
|
| Time Factors | 2 | 2005 | 4655 | 0.010 |
Why?
|
| Cytarabine | 1 | 2000 | 44 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2004 | 700 | 0.010 |
Why?
|
| Muramidase | 1 | 2000 | 38 | 0.010 |
Why?
|
| Fatal Outcome | 1 | 2000 | 164 | 0.010 |
Why?
|
| Cytokines | 1 | 2004 | 866 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2003 | 1745 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2000 | 305 | 0.010 |
Why?
|
| Models, Biological | 1 | 2003 | 981 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2002 | 1046 | 0.010 |
Why?
|
| Risk Factors | 2 | 2002 | 5731 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2002 | 1553 | 0.010 |
Why?
|
| Cyclin E | 1 | 1997 | 19 | 0.010 |
Why?
|
| Methods | 1 | 1977 | 156 | 0.010 |
Why?
|
| Genetic Markers | 1 | 1998 | 144 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase 2 | 1 | 1997 | 33 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2001 | 786 | 0.010 |
Why?
|
| Cytidine Monophosphate | 1 | 1997 | 1 | 0.010 |
Why?
|
| Seminiferous Tubules | 1 | 1997 | 3 | 0.010 |
Why?
|
| Retinoic Acid Receptor alpha | 1 | 1997 | 9 | 0.010 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 1997 | 22 | 0.010 |
Why?
|
| Recurrence | 1 | 2000 | 948 | 0.010 |
Why?
|
| Immunoglobulin lambda-Chains | 1 | 1997 | 10 | 0.010 |
Why?
|
| High Mobility Group Proteins | 1 | 1997 | 7 | 0.010 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 1997 | 60 | 0.010 |
Why?
|
| Chimera | 1 | 1997 | 33 | 0.010 |
Why?
|
| Bromcresol Green | 1 | 1997 | 2 | 0.010 |
Why?
|
| HeLa Cells | 1 | 1997 | 237 | 0.010 |
Why?
|
| Blood Preservation | 1 | 1997 | 13 | 0.010 |
Why?
|
| ABO Blood-Group System | 1 | 1997 | 15 | 0.010 |
Why?
|
| Adenosine Monophosphate | 1 | 1997 | 41 | 0.010 |
Why?
|
| Immunoglobulin kappa-Chains | 1 | 1997 | 30 | 0.010 |
Why?
|
| DNA Footprinting | 1 | 1996 | 4 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 1997 | 351 | 0.010 |
Why?
|
| Filtration | 1 | 1997 | 61 | 0.010 |
Why?
|
| Quality Control | 1 | 1997 | 81 | 0.010 |
Why?
|
| Immunoblotting | 1 | 1997 | 254 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1996 | 272 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2002 | 1851 | 0.010 |
Why?
|
| Molecular Biology | 1 | 1996 | 31 | 0.010 |
Why?
|
| Molecular Weight | 1 | 1996 | 358 | 0.010 |
Why?
|
| Plasmids | 1 | 1997 | 258 | 0.010 |
Why?
|
| Anemia | 1 | 1997 | 104 | 0.010 |
Why?
|
| Hypoxia | 1 | 1997 | 169 | 0.010 |
Why?
|
| Prostate-Specific Antigen | 1 | 1996 | 138 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 1998 | 792 | 0.010 |
Why?
|
| Transfection | 1 | 1997 | 782 | 0.010 |
Why?
|
| Adenosine Triphosphate | 1 | 1997 | 314 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p15 | 1 | 1995 | 7 | 0.010 |
Why?
|
| Homozygote | 1 | 1995 | 119 | 0.010 |
Why?
|
| Homeostasis | 1 | 1997 | 291 | 0.010 |
Why?
|
| Down-Regulation | 1 | 1997 | 447 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 1995 | 51 | 0.010 |
Why?
|
| Lymphatic Metastasis | 1 | 1996 | 274 | 0.010 |
Why?
|
| Gene Expression | 1 | 1997 | 770 | 0.010 |
Why?
|
| Incidence | 1 | 1999 | 1603 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 1997 | 1083 | 0.010 |
Why?
|
| Biopsy | 1 | 1996 | 540 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 1997 | 481 | 0.010 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 1996 | 231 | 0.010 |
Why?
|
| Binding Sites | 1 | 1995 | 631 | 0.010 |
Why?
|
| Infant, Newborn | 3 | 1985 | 2455 | 0.010 |
Why?
|
| Skin | 1 | 1997 | 451 | 0.010 |
Why?
|
| Skin Neoplasms | 1 | 1998 | 375 | 0.010 |
Why?
|
| Adenocarcinoma | 1 | 1996 | 475 | 0.010 |
Why?
|
| Child | 1 | 2004 | 6405 | 0.010 |
Why?
|
| Educational Status | 1 | 1993 | 273 | 0.010 |
Why?
|
| Blood Urea Nitrogen | 1 | 1972 | 65 | 0.010 |
Why?
|
| Radioimmunoassay | 1 | 1972 | 164 | 0.010 |
Why?
|
| Biomarkers | 1 | 1996 | 1593 | 0.010 |
Why?
|
| Sex Factors | 1 | 1993 | 1266 | 0.010 |
Why?
|
| Chronic Disease | 2 | 1986 | 1330 | 0.010 |
Why?
|
| Apoptosis | 1 | 1996 | 1641 | 0.010 |
Why?
|
| Prevalence | 1 | 1993 | 1619 | 0.010 |
Why?
|
| Blood Glucose | 1 | 1972 | 631 | 0.000 |
Why?
|
| Cohort Studies | 1 | 1993 | 2358 | 0.000 |
Why?
|
| Maternal-Fetal Exchange | 1 | 1985 | 57 | 0.000 |
Why?
|
| Surveys and Questionnaires | 1 | 1993 | 2800 | 0.000 |
Why?
|
| Injections, Intraperitoneal | 1 | 1984 | 89 | 0.000 |
Why?
|
| Mice, Inbred BALB C | 1 | 1985 | 532 | 0.000 |
Why?
|
| Cricetinae | 1 | 1984 | 262 | 0.000 |
Why?
|
| Carcinoma, Ehrlich Tumor | 1 | 1984 | 5 | 0.000 |
Why?
|
| Leukemia L1210 | 1 | 1984 | 14 | 0.000 |
Why?
|
| Drug Evaluation | 1 | 1984 | 47 | 0.000 |
Why?
|
| Disease Susceptibility | 1 | 1984 | 179 | 0.000 |
Why?
|
| Mice, Inbred Strains | 1 | 1984 | 181 | 0.000 |
Why?
|
| Neoplasm Transplantation | 1 | 1984 | 160 | 0.000 |
Why?
|
| Plasmapheresis | 1 | 1982 | 18 | 0.000 |
Why?
|
| Infant, Newborn, Diseases | 1 | 1982 | 91 | 0.000 |
Why?
|
| Adrenal Cortex Hormones | 1 | 1982 | 186 | 0.000 |
Why?
|
| Cell Line | 1 | 1984 | 1752 | 0.000 |
Why?
|